Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia
Clinical trial NCT07034690 · RECRUITING
Trial details
- NCT number
- NCT07034690
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-26
- Primary completion
- 2027-05-31
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.